Date published: 2026-2-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nicardipine hydrochloride (CAS 54527-84-3)

5.0(2)
Write a reviewAsk a question

See product citations (5)

Alternate Names:
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)methyl-2-[methyl(phenylmethyl)amino]-3,5-pyridinedicarboxylic acid ethyl ester hydrochloride; YC-93
Application:
Nicardipine hydrochloride is a potent calcium channel protein inhibitor
CAS Number:
54527-84-3
Purity:
≥98%
Molecular Weight:
515.98
Molecular Formula:
C26H29N3O6•HCl
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Nicardipine hydrochloride is a chemical compound that falls within the class of biochemicals known as calcium channel blockers. It has a specific affinity for blocking L-type calcium channels, which are primarily found in the cardiovascular system. The structure of nicardipine hydrochloride includes a dihydropyridine ring, which is crucial for its activity as it interacts with the calcium channels to modulate the influx of calcium ions. By influencing the movement of calcium ions, nicardipine hydrochloride helps to alter the contractility and conductivity of cardiac muscle and smooth muscle cells. This action is particularly relevant in studies aimed at understanding calcium dynamics within vascular smooth muscle cells, as it affects vasodilation and vasoconstriction mechanisms. In a broader scientific application, nicardipine hydrochloride is used to investigate the role of calcium channels in various physiological and pathological processes. Its ability to specifically target L-type calcium channels makes it an important tool for understanding the contributions of these channels to cellular functions and for exploring potential interventions in conditions related to abnormal calcium channel activity.


Nicardipine hydrochloride (CAS 54527-84-3) References

  1. Stereoselective and endothelium-independent action of nicardipine on the isolated porcine coronary artery.  |  Japelj, I., et al. 1999. Eur J Pharmacol. 369: 43-7. PMID: 10204680
  2. Effect of calcium channel antagonists nifedipine and nicardipine on rat cytochrome P-450 2B and 3A forms.  |  Zangar, RC., et al. 1999. J Pharmacol Exp Ther. 290: 1436-41. PMID: 10454523
  3. Effects of nicardipine and bupivacaine on early after depolarization in rabbit sinoatrial node cells: a possible mechanism of bupivacaine-induced arrhythmias.  |  Matsuda, T. and Kurata, Y. 1999. Gen Pharmacol. 33: 115-25. PMID: 10461849
  4. Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126.  |  Thellung, S., et al. 2000. Neurobiol Dis. 7: 299-309. PMID: 10964602
  5. Enhanced percutaneous permeability of nicardipine hydrochloride by carvone across the rat abdominal skin.  |  Krishnaiah, YS., et al. 2003. Drug Dev Ind Pharm. 29: 191-202. PMID: 12648016
  6. The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride.  |  Wu, PC., et al. 2010. Drug Dev Ind Pharm. 36: 1398-403. PMID: 20545507
  7. Polymorphs and solvates of nicardipine hydrochloride. Selective stabilization of different diastereomeric racemates.  |  Moreno-Calvo, E., et al. 2011. Mol Pharm. 8: 395-404. PMID: 21166472
  8. Effect of nicardipine hydrochloride on circulating blood volume and vascular compliance in dogs.  |  Hashimoto, S., et al. 1990. Jpn Circ J. 54: 146-51. PMID: 2355450
  9. Characterization of nicardipine hydrochloride-induced cell injury in human vascular endothelial cells.  |  Ochi, M., et al. 2015. J Toxicol Sci. 40: 71-6. PMID: 25743564
  10. 1,4-Dihydropyridine activators and antagonists: structural and functional distinctions.  |  Triggle, DJ. and Rampe, D. 1989. Trends Pharmacol Sci. 10: 507-11. PMID: 2694544
  11. Effect of nicardipine hydrochloride on regional hypoxic pulmonary vasoconstriction.  |  Nakazawa, K. and Amaha, K. 1988. Br J Anaesth. 60: 547-54. PMID: 3132192
  12. Solubilization of nicardipine hydrochloride via complexation and salt formation.  |  Maurin, MB., et al. 1994. J Pharm Sci. 83: 1418-20. PMID: 7884662
  13. Stability of nicardipine hydrochloride in intravenous solutions.  |  Baaske, DM., et al. 1996. Am J Health Syst Pharm. 53: 1701-5. PMID: 8827237

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Nicardipine hydrochloride, 1 g

sc-202731
1 g
$33.00

Nicardipine hydrochloride, 5 g

sc-202731A
5 g
$83.00